Antares Pharma Inc

Type: Company
Name: Antares Pharma Inc
Nationality: United States
Web Address: http://www.antarespharma.com/
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

5 Breakout Stocks Under $10 Set to Soar

aDELAFIELD, Wis. (Stockpickr) --aThere isn't a day that goes by on Wall Street when certain stocks trading for under $10 a share don't experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline ... [Published The Street Latest - Aug 28 2014]
Entities: Stocks, Neon, Moving Average
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

ANTARES PHARMA : "Two-Stage Reconstituting Injector" in Patent Application Approval Process

By a News Reporter-Staff News Editor at Biotech Week -- A patent application by the inventors KRAMER, Thomas E. ( Coon Rapids, MN ); SADOWSKI, Peter L. ( Woodbury, MN ), filed on April 4, 2014 , was made available online on August 14, 2014 , according ... [Published 4 Traders - Aug 20 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Insider Buying: Antares Pharma Director Purchases 5,000 Shares of Stock (ATRS)

Antares Pharma (NASDAQ:ATRS) Director Robert P. Roche, Jr. purchased 5,000 shares of the company’s stock on the open market in a transaction dated Wednesday, August 13th. The stock was purchased at an average price of $1.96 per share, with a total value ... [Published American Banking News - Forex - Aug 18 2014]
First reported Aug 16 2014 - Updated Aug 16 2014 - 1 reports

Insider Buying: Antares Pharma Director Acquires 5,000 Shares of Stock (ATRS)

Antares Pharma (NASDAQ:ATRS) Director Robert P. Roche, Jr. purchased 5,000 shares of Antares Pharma stock on the open market in a transaction dated Wednesday, August 13th. The stock was purchased at an average cost of $1.96 per share, for a total transaction ... [Published American Banking News - Forex - Aug 16 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

Antares Pharma's (ATRS) CEO Paul Wotton on Q2 2014 Results - Earnings Call Transcript

Ladies and gentlemen, welcome to the Antares Pharma Second Quarter 2014 Operating and Financial Results Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode. After the presentation, there will be an ... [Published Seeking Alpha - Aug 08 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 2 reports

Antares Pharma Ranks the Highest in Terms of Revenue Per Employee in the Health Care Supplies Industry (AIS, VIVO, ELGX)

(Financial News Network On) Below are the three companies in the Health Care Supplies industry with the highest Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the productivity of companies in the same industry.Antares Pharma (AMEX:AIS) ... [Published Individual.com - Aug 08 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 1 reports

Antares Pharma EPS in-line, misses on revenue

07:26 ET | About: Antares Pharma Inc. (ATRS)Antares Pharma (NASDAQ:ATRS): Q2 EPS of -$0.07 in-line.Revenue of $6.32M (+8.2% Y/Y) misses by $ ... [Published Seeking Alpha - Aug 07 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 2 reports

Antares Pharma, Inc. Reports Second Quarter 2014 Operating And Financial Results

Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the second quarter ended June 30, 2014.Quarter and Recent Highlights•Increased number of unique prescribers of OTREXUP™ to over 600 total physicians as of June 30, ... [Published BioSpace - Aug 07 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 2 reports

Global Transdermal Drug Delivery Market 2014-2018: Key Vendors are ANI Pharmaceuticals, Antares Pharma, Bayer, Janssen and Novartis

http://photos.prnewswire.com/prnh/20130307/600769Transdermal drug delivery is a large and growing vertical market of the Pharmaceutical industry. Transdermal drug delivery is defined as a system that utilizes skin as a site for continuous drug administration ... [Published Indianapolis Business Journal - Aug 07 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 1 reports

Antares Pharma (ATRS) Releases Quarterly Earnings Results, Meets Expectations

Antares Pharma (NASDAQ:ATRS) issued its quarterly earnings data on Thursday. The company reported ($0.07) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.07), StockRatingsNetwork.com reports. The company had revenue ... [Published American Banking News - Forex - Aug 07 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Global Transdermal Drug Delivery Market 2014-2018: Key Vendors are ANI Pharmaceuticals, Antares Pharma, Bayer, Janssen and Novartis

Dublin, Aug. 6, 2014 (GLOBE NEWSWIRE) -- First, the method of delivery is non-invasive, which is much less traumatic to the patient as compared to other forms of drug delivery. Also, it can be effective in assuring that a patient receives a full dosage ... [Published Wall Street Select - Aug 06 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 4 reports

Antares Pharma to Host Second Quarter 2014 Operating and Financial Results Conference Call

EWING, N.J.--(EON: Enhanced Online News)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its second quarter 2014 financial results before the market opens on Thursday, August 7, 2014, and host a conference call shortly thereafter ... [Published EON Science - Jul 31 2014]

Quotes

The following quote was obtained by the news editors from the background information supplied by the inventors: "Known injection devices for injection of medicaments into a patient include traditional hypodermic needle syringes, needle-free jet injectors like the ones disclosed in U S Pat. Nos. 5,599,302; 5,062,830; and 4,790,824; needle-assisted injectors, such as those described in U S Patent Publication No. 2005/0033234; and self-injectors or autoinjectors like the ones disclosed in U S Pat. Nos. 4,553,962 and 4,378,015, and PCT Publications WO 95/29720 and WO 97/14455."

More Content

All (77) | News (19) | Reports (0) | Blogs (51) | Audio/Video (0) | Fact Sheets (0) | Press Releases (7)
sort by: Date | Relevance
5 Breakout Stocks Under $10 Set to Soar [Published The Street Latest - Aug 28 2014]
Self-administration of Subcutaneous Methotrexate [Published Diabetes Care - Aug 26 2014]
ANTARES PHARMA : "Two-Stage Reconstituting Inje... [Published 4 Traders - Aug 20 2014]
Health Care Equipment and Supplies Equities Scr... [Published Financial Services - Aug 18 2014]
Insider Buying: Antares Pharma Director Purchas... [Published American Banking News - Forex - Aug 18 2014]
Insider Buying: Antares Pharma Director Acquire... [Published American Banking News - Forex - Aug 16 2014]
Antares Pharma's (ATRS) CEO Paul Wotton on Q2 2... [Published Seeking Alpha - Aug 08 2014]
Antares Pharma Ranks the Highest in Terms of Re... [Published Individual.com - Aug 08 2014]
Antares Pharma Ranks the Highest in Term... [Published Financial News Network online - Aug 08 2014]
Antares Pharma, Inc. Reports Second Quarter 201... [Published BioSpace - Aug 07 2014]
Global Transdermal Drug Delivery Market 2014-20... [Published Indianapolis Business Journal - Aug 07 2014]
Global Transdermal Drug Delivery Market 2014-20... [Published PR Newswire: General Business - Aug 07 2014]
Antares Pharma (ATRS) Releases Quarterly Earnin... [Published American Banking News - Forex - Aug 07 2014]
Antares Pharma EPS in-line, misses on revenue [Published Seeking Alpha - Aug 07 2014]
Antares Pharma Reports Second Quarter 2014 Oper... [Published Business Wire Health News - Aug 07 2014]
Global Transdermal Drug Delivery Market 2014-20... [Published GlobeNewswire: Advertising News - Aug 06 2014]
Global Transdermal Drug Delivery Market 2014-20... [Published Wall Street Select - Aug 06 2014]
Global Transdermal Drug Delivery market will gr... [Published Live-PR.com - Aug 06 2014]
Antares Pharma to Host Second Quarter 2014 Oper... [Published EON Science - Jul 31 2014]
Antares Pharma to Host Second Quarter 2014 Oper... [Published Myrtle Beach Sun News - Jul 31 2014]
Antares Pharma to Host Second Quarter 2014 Oper... [Published Business Wire Science: Science News - Jul 31 2014]
Antares Pharma to Host Second Quarter 2014 Oper... [Published Business Wire Health News - Jul 31 2014]
Antares starts dosing in Phase III QuickShot tr... [Published PBR - News - Jul 23 2014]
Antares Pharma Announces First Patient Dosed in... [Published EON Science - Jul 22 2014]
Antares Pharma Announces First Patient Dosed in... [Published Business Wire Science: Science News - Jul 22 2014]
Antares Pharma Announces First Patient Dosed in... [Published Business Wire Health News - Jul 22 2014]
2nd Quarter Executive Turnover Remains Positive... [Published Management Turnover as Change Agent - Jul 17 2014]
FDA’s Intervening NDA Approval Policy Strikes A... [Published FDA Law Blog - Jul 17 2014]
Research and Markets: Global Transdermal Drug D... [Published Business Wire Health News - Jul 16 2014]
US FDA approves Medac Pharma's Rasuvo injection... [Published PharmaBiz - Jul 15 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Global Transdermal Drug Delivery Market 2014-20... [Published PR Newswire: General Business - Aug 07 2014]
DUBLIN, Aug. 7, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Transdermal Drug Delivery Market 2014-2018" report to their offering.http://photos.prnewswire.com/prnh/20130307/600769Transdermal drug delivery is a large ...
Antares Pharma Reports Second Quarter 2014 Oper... [Published Business Wire Health News - Aug 07 2014]
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the second quarter ended June 30, 2014. Quarter and Recent Highlights Increased number of unique prescribers of OTREXUP™ to over 600 total ...
Antares Pharma to Host Second Quarter 2014 Oper... [Published EON Science - Jul 31 2014]
EWING, N.J.--(EON: Enhanced Online News)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its second quarter 2014 financial results before the market opens on Thursday, August 7, 2014, and host a conference call shortly thereafter ...
Antares Pharma to Host Second Quarter 2014 Oper... [Published Business Wire Science: Science News - Jul 31 2014]
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its second quarter 2014 financial results before the market opens on Thursday, August 7, 2014, and host a conference call shortly thereafter at 8:30 a.m. ...
Antares Pharma to Host Second Quarter 2014 Oper... [Published Business Wire Health News - Jul 31 2014]
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its second quarter 2014 financial results before the market opens on Thursday, August 7, 2014, and host a conference call shortly thereafter at 8:30 a.m. ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Health Care Equipment and Supplies Equities Scr... [Published Financial Services - Aug 18 2014]
Global Transdermal Drug Delivery Market 2014-20... [Published GlobeNewswire: Advertising News - Aug 06 2014]
Pre-Market Pulse on Health Care Stocks -- Resea... [Published Financial Services - Jul 10 2014]
Pre-market Equity Watch on Health Care Equipmen... [Published Financial Services - Jun 19 2014]
Analysts View on Health Care Sector Equities --... [Published Financial Services - Apr 30 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.